Clinical Trial Update: Bupropion as an Adjunct to the Nicotine Patch Plus CBT [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating bupropion as an adjunct to nicotine patch therapy and cognitive behavioral therapy for tobacco use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Phase 4 | Status: COMPLETED